Russell Howerton to Adenocarcinoma
This is a "connection" page, showing publications Russell Howerton has written about Adenocarcinoma.
Connection Strength
0.330
-
Enomoto LM, Fenstermaker J, Desnoyers RJ, Pasche BC, Blackstock AW, Howerton RM, Clark CJ, Levine EA, Shen P. Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy. Ann Surg Oncol. 2019 May; 26(5):1512-1518.
Score: 0.133
-
Mishra G, Zhao Y, Sweeney J, Pineau BC, Case D, Ho C, Blackstock AW, Geisinger K, Howerton R, Levine E, Shen P, Ibdah J. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2006 Apr; 63(4):648-54.
Score: 0.055
-
Mishra G, Butler J, Ho C, Melin S, Case LD, Ennever PR, Magrinat GC, Bearden JD, Minotto DC, Howerton R, Levine E, Blackstock AW. Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. Am J Clin Oncol. 2005 Aug; 28(4):345-50.
Score: 0.052
-
Hawksworth J, Geisinger K, Zagoria R, Kavanagh P, Howerton R, Levine EA, Shen P. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg. 2004 Jun; 70(6):512-7.
Score: 0.048
-
Blackstock AW, Melin SA, Butler JM, Patton S, Pineau B, Albertson D, Howerton R, Levine E. Irinotecan/gemcitabine followed by twice-weekly gemcitabine/radiation in locally advanced pancreatic cancer. Oncology (Williston Park). 2002 May; 16(5 Suppl 5):25-8.
Score: 0.042